Загрузка видео...

Не удалось загрузить видео

На главную

How can generative AI and Robotics help advance drug discovery？ 🚀 Excited to introduce LUMI-lab! A foundation model-driven Self-Driving Lab (SDL) for autonomous ionizable lipid discovery in mRNA delivery 🤖🔍 🔬 What is LUMI-lab? LUMI-lab integrates molecular foundation models with autonomous robotic experiments to efficiently explore new LNPs (lipid...

BoWang87's profile picture

Bo Wang

30,501 subscribers

27,567 просмотров • 1 год назад •via X (Twitter)

Наука и технологииОбразованиеЗдоровье и велнес
LIVE

Anya Rossi• Live Now

Private livecam show

Комментарии: 11

Фото профиля Melinda B. Chu
Melinda B. Chu1 год назад

Super cool! I’m going to try to include it in an upcoming project! 🤩👩🏻‍🔬🤖🦾

Фото профиля The Information
The Information1 год назад

OpenAI is betting on a little-known startup to stay ahead of Elon Musk in the supercomputer race.

Фото профиля Derya Unutmaz, MD
Derya Unutmaz, MD1 год назад

This is incredible! 👏👏👏

Фото профиля Bo Wang
Bo Wang1 год назад

Thanks Derya for all your support!

Фото профиля Matt Greving
Matt Greving1 год назад

Very nice!

Фото профиля Tigger
Tigger1 год назад

wow 🫡

Фото профиля Trevor Campbell
Trevor Campbell1 год назад

Woah… this is very cool! And very timely — There is a lot of LNP exploration and testing in my near future Will definitely be digging deep on this one!

Фото профиля ashutosh
ashutosh1 год назад

@AdrianoAguzzi Greetings, this looks like the right robot for your lab? thank you.

Фото профиля Prasad Kothari (he/him/his)
Prasad Kothari (he/him/his)1 год назад

Great work. Congratulations & all the best. Good to see Lumi working on drug discovery.

Фото профиля J Sam🌐
J Sam🌐1 год назад

Is CAD also opensourced?

Фото профиля Sabeer Saeed
Sabeer Saeed1 год назад

Super Outstanding!

Похожие видео

Did you know that lipid nanoparticles (LNPs) have been studied for decades? The science behind mRNA technology isn't "new," and unfortunately, neither are its historical failures in animal testing. Kelly Victory MD
1:32

Did you know that lipid nanoparticles (LNPs) have been studied for decades? The science behind mRNA technology isn't "new," and unfortunately, neither are its historical failures in animal testing. Kelly Victory MD

Mary Talley Bowden MD

15,985 просмотров • 3 месяцев назад

High-quality experimental data fuels biological discovery. Could an AI-enabled "autonomous lab" fundamentally increase the rate at which we generate it, and accelerate our progress toward cures for disease? That's the question I sat down to explore with Jason Kelly, CEO of Ginkgo Bioworks, for a deep-dive and tour of their 52-RAC lab in Boston's Seaport District. In our conversation we covered: → Ginkgo's recent collaboration with OpenAI on cell-free protein synthesis → U.S. Department of Energy's POTUS-backed Genesis Mission to accelerate AI for science → The evolution from cloud labs to truly autonomous labs → An on-the-floor look at Ginkgo's lab, including early challenges and creative workarounds If you're curious about frontier AI models meet the lab bench, check out the latest episode of the Discovery Engines Podcast. Watch or listen: 👀 YouTube: 🎧 Spotify: 🎧 Apple:
0:29

High-quality experimental data fuels biological discovery. Could an AI-enabled "autonomous lab" fundamentally increase the rate at which we generate it, and accelerate our progress toward cures for disease? That's the question I sat down to explore with Jason Kelly, CEO of Ginkgo Bioworks, for a deep-dive and tour of their 52-RAC lab in Boston's Seaport District. In our conversation we covered: → Ginkgo's recent collaboration with OpenAI on cell-free protein synthesis → U.S. Department of Energy's POTUS-backed Genesis Mission to accelerate AI for science → The evolution from cloud labs to truly autonomous labs → An on-the-floor look at Ginkgo's lab, including early challenges and creative workarounds If you're curious about frontier AI models meet the lab bench, check out the latest episode of the Discovery Engines Podcast. Watch or listen: 👀 YouTube: 🎧 Spotify: 🎧 Apple:

Nabil Laoudji

11,508 просмотров • 3 месяцев назад

What could scaling unlock for biology? Introducing ProGen3- our next AI foundation models for protein generation. We develop compute-optimal scaling laws up to 46B parameters on 1.5T tokens with real evidence in the wet lab. +we solve a new set of challenges for drug discovery
2:36

What could scaling unlock for biology? Introducing ProGen3- our next AI foundation models for protein generation. We develop compute-optimal scaling laws up to 46B parameters on 1.5T tokens with real evidence in the wet lab. +we solve a new set of challenges for drug discovery

Ali Madani

80,642 просмотров • 1 год назад

GPT-5.4 helped drive a medicinal chemistry project from literature review to a validated experimental result. Paired with Maria AI and specialized lab, the model proposed an unexpected way to improve a widely used reaction in drug discovery.
0:29

GPT-5.4 helped drive a medicinal chemistry project from literature review to a validated experimental result. Paired with Maria AI and specialized lab, the model proposed an unexpected way to improve a widely used reaction in drug discovery.

OpenAI

480,766 просмотров • 15 дней назад

Proud to announce that Ginkgo Bioworks was awarded a $47M contract to kick off President Trump's new Genesis Mission and build the world's largest autonomous lab at Pacific Northwest National Lab! I was honored to join Secretary Chris Wright as he commissioned the first phase of the lab yesterday at PNNL 🇺🇸🤖 Autonomous labs allow scientists to order experiments just by asking for them and are a key component for AI models to accelerate science at the scale outlined in the Genesis Project by Director Michael Kratsios, Dario Gil, Sriram Krishnan. More below, including some behind the scenes footage 😀
5:28

Proud to announce that Ginkgo Bioworks was awarded a $47M contract to kick off President Trump's new Genesis Mission and build the world's largest autonomous lab at Pacific Northwest National Lab! I was honored to join Secretary Chris Wright as he commissioned the first phase of the lab yesterday at PNNL 🇺🇸🤖 Autonomous labs allow scientists to order experiments just by asking for them and are a key component for AI models to accelerate science at the scale outlined in the Genesis Project by Director Michael Kratsios, Dario Gil, Sriram Krishnan. More below, including some behind the scenes footage 😀

Jason Kelly

202,252 просмотров • 6 месяцев назад

🆕!! AI and atomic-level structure prediction are accelerating drug discovery — turning a slow, empirical search process into something closer to molecular engineering. Joshua Meier @_jackdent co-founders Chai Discovery chat their new bio foundation model, Chai-2. It enables zero-shot antibody discovery in a single 24-well plate — with a ~20% hit rate, compressing years of lab work into weeks. They talk what's next for Chai, what's still challenging, and why they're 𝐛𝐮𝐥𝐥𝐢𝐬𝐡 𝐨𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡
0:51

🆕!! AI and atomic-level structure prediction are accelerating drug discovery — turning a slow, empirical search process into something closer to molecular engineering. Joshua Meier @_jackdent co-founders Chai Discovery chat their new bio foundation model, Chai-2. It enables zero-shot antibody discovery in a single 24-well plate — with a ~20% hit rate, compressing years of lab work into weeks. They talk what's next for Chai, what's still challenging, and why they're 𝐛𝐮𝐥𝐥𝐢𝐬𝐡 𝐨𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡

No Priors

14,840 просмотров • 1 год назад

Agree, this is an important point from Michael Baym. A Waymo is an autonomous car even if a human is in the back seat telling it where to go. Same for an Autonomous Lab, scientists can tell it what protocols to do -- quick autonomous lab explainer in this video. It's really about solving for variable lab work, not about taking the scientist out of the loop.
2:39

Agree, this is an important point from Michael Baym. A Waymo is an autonomous car even if a human is in the back seat telling it where to go. Same for an Autonomous Lab, scientists can tell it what protocols to do -- quick autonomous lab explainer in this video. It's really about solving for variable lab work, not about taking the scientist out of the loop.

Jason Kelly

21,375 просмотров • 3 месяцев назад

.Argonne National Lab's Center for Nanoscale Materials and The University of Chicago CASE scientist Jie Xu created a self-driving lab using #AI and robotics to free up scientists, streamline experiments, save resources and accelerate the pace of discovery. More at
0:35

.Argonne National Lab's Center for Nanoscale Materials and The University of Chicago CASE scientist Jie Xu created a self-driving lab using #AI and robotics to free up scientists, streamline experiments, save resources and accelerate the pace of discovery. More at

UChicago Pritzker Molecular Engineering

12,702 просмотров • 3 лет назад

"It's a permanent fixture of their genome now" "Can the little pieces of DNA that are in the [Pfizer mRNA] vaccine ever get into the human genome?": “The Pfizer vaccine is contaminated with Plasmid DNA, it's not just mRNA...it's got bits of DNA in it [and I know] because I sequenced it in my own lab” Phillip Buckhaults, PhD Biochemistry and Molecular Biology. Scientist & Professor of Molecular Biology & Genetics
0:58

"It's a permanent fixture of their genome now" "Can the little pieces of DNA that are in the [Pfizer mRNA] vaccine ever get into the human genome?": “The Pfizer vaccine is contaminated with Plasmid DNA, it's not just mRNA...it's got bits of DNA in it [and I know] because I sequenced it in my own lab” Phillip Buckhaults, PhD Biochemistry and Molecular Biology. Scientist & Professor of Molecular Biology & Genetics

Humanspective

39,623 просмотров • 11 месяцев назад

Turns out his company was the one that produced the LNPs for the mRNA shots. Let's see what he has to say about where the LNPs go...
0:45

Turns out his company was the one that produced the LNPs for the mRNA shots. Let's see what he has to say about where the LNPs go...

SoothSpider 🇨🇦🍁🧡真🔬💻Ω 🐶😼🌎

54,248 просмотров • 2 лет назад

The FDA knew for years the dangers of MRNA. Lawyer Tom Renz has a 2006 document where the FDA acknowledge the MRNA gene therapy products had the potential to cause cancer in the long term. Now confirmed by their own lab findings of high level DNA contamination in the shots. The MRNA platform needs to be shut down.
1:49

The FDA knew for years the dangers of MRNA. Lawyer Tom Renz has a 2006 document where the FDA acknowledge the MRNA gene therapy products had the potential to cause cancer in the long term. Now confirmed by their own lab findings of high level DNA contamination in the shots. The MRNA platform needs to be shut down.

Kat A 🌸

63,189 просмотров • 1 год назад

"You just had a huge bioleak in Seattle" A lab working on a product like Pfizer’s mRNA vaccine, found out it appeared to be transmissible, like “self replicating vaccine” technology The lab workers infected their housemates Genomics expert Kevin McKernan tells a story about the lab in Seattle that was working on something similar to Pfizer's mRNA covid vaccine, which somehow infected the researchers, who then infected their Housemates "Hundreds of labs around the world doing this". He said this particular issue, [where] hundreds of labs [are] cloning different forms of the spike protein into vectors that can shuttle between mammals and E. coli, is very concerning
4:20

"You just had a huge bioleak in Seattle" A lab working on a product like Pfizer’s mRNA vaccine, found out it appeared to be transmissible, like “self replicating vaccine” technology The lab workers infected their housemates Genomics expert Kevin McKernan tells a story about the lab in Seattle that was working on something similar to Pfizer's mRNA covid vaccine, which somehow infected the researchers, who then infected their Housemates "Hundreds of labs around the world doing this". He said this particular issue, [where] hundreds of labs [are] cloning different forms of the spike protein into vectors that can shuttle between mammals and E. coli, is very concerning

Humanspective

69,957 просмотров • 1 год назад

In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it. The hard problem in AI for science is at the interface between the physical and digital worlds. We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast. Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.
1:44

In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it. The hard problem in AI for science is at the interface between the physical and digital worlds. We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast. Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.

Sajith Wickramasekara

30,514 просмотров • 2 месяцев назад

New Unsupervised Learning with Joshua Meier @ NeurIPS (Chai Discovery) on how AI x drug discovery is starting to inflect and: - The 3 waves of AI biotech - How AI models think differently than chemists - Building "Photoshop for molecules" - Deciding what to open source
0:38

New Unsupervised Learning with Joshua Meier @ NeurIPS (Chai Discovery) on how AI x drug discovery is starting to inflect and: - The 3 waves of AI biotech - How AI models think differently than chemists - Building "Photoshop for molecules" - Deciding what to open source

Jacob Effron

12,351 просмотров • 10 месяцев назад

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch
0:38

ReaSyn is helping to revolutionize drug discovery 🔬 Our new generative AI predicts synthetic pathways for molecules using step-by-step reasoning accelerating drug discovery and scientific breakthroughs. Read more and try the code ➡️ #NVIDIAResearch

NVIDIA AI Developer

25,451 просмотров • 9 месяцев назад

Blank Bio (Blank Bio) is building foundation models to power a computational toolkit for RNA therapeutics, starting with mRNA design and expanding to target ID, biomarker discovery, and more. Congrats on the launch, Jonny, Phil Fradkin & Ian Shi!
2:56

Blank Bio (Blank Bio) is building foundation models to power a computational toolkit for RNA therapeutics, starting with mRNA design and expanding to target ID, biomarker discovery, and more. Congrats on the launch, Jonny, Phil Fradkin & Ian Shi!

Y Combinator

96,728 просмотров • 11 месяцев назад

Introducing LiteFold DeNovo. Generate hundreds of chemically viable ligands against any protein pocket, evaluate them in real time, and refine with our built in molecular editor. The problem: hit generation in drug discovery is slow, fragmented, and outsourced. With LiteFold DeNovo, it becomes interactive and instant. You can also fragment grow base generated molecules, iterate, and soon run molecular dynamics to test stability. Docking and large scale screening are on the way. When we said we’re building the AI first lab for drug discovery, we meant it. Super excited to what's coming next. Codename: Rosalind Try LiteFold DeNovo today. It’s free. Links in the comments.
1:37

Introducing LiteFold DeNovo. Generate hundreds of chemically viable ligands against any protein pocket, evaluate them in real time, and refine with our built in molecular editor. The problem: hit generation in drug discovery is slow, fragmented, and outsourced. With LiteFold DeNovo, it becomes interactive and instant. You can also fragment grow base generated molecules, iterate, and soon run molecular dynamics to test stability. Docking and large scale screening are on the way. When we said we’re building the AI first lab for drug discovery, we meant it. Super excited to what's coming next. Codename: Rosalind Try LiteFold DeNovo today. It’s free. Links in the comments.

Anindya

23,157 просмотров • 10 месяцев назад

Come visit our Autonomous lab for a tour ! Its crazy to see in person — but I made a little behind the scenes video on what makes an autonomous lab different from a traditional lab automation workcell! Sign up here for a tour next week at 25 Drydock ave in boston !
2:32

Come visit our Autonomous lab for a tour ! Its crazy to see in person — but I made a little behind the scenes video on what makes an autonomous lab different from a traditional lab automation workcell! Sign up here for a tour next week at 25 Drydock ave in boston !

Jason Kelly

36,781 просмотров • 4 месяцев назад

See a video tour of the first Autonomous Lab built for the Genesis Mission by Ginkgo Bioworks at Pacific Northwest National Laboratory !🇺🇸🤖 US keeping lead in science needs scientists driving AI+robots instead of toiling at the lab bench!
2:07

See a video tour of the first Autonomous Lab built for the Genesis Mission by Ginkgo Bioworks at Pacific Northwest National Laboratory !🇺🇸🤖 US keeping lead in science needs scientists driving AI+robots instead of toiling at the lab bench!

Jason Kelly

39,832 просмотров • 2 месяцев назад

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception
1:55

About 15% of the world’s population — over a billion people — are affected by neurological disorders. BrainStorm, a San Diego-based startup, is accelerating the development of cures for these conditions using AI-powered computational drug discovery paired with lab experiments using organoids: tiny, 3D bundles of brain cells created from patient-derived stem cells. This hybrid, iterative method, where clinical data and AI models inform one another to accelerate drug development. Learn more ➡️ #NVIDIAInception

NVIDIA AI Developer

26,637 просмотров • 1 год назад